Hepatitis C virus infection and cryoglobulinemia

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 848-855

  Lunel, Françoise ^a   Musset, Lucile ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; RECOMBINANT ALPHA INTERFERON;

CRYOGLOBULINEMIA; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GENETIC PREDISPOSITION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LEUKOCYTOCLASTIC VASCULITIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW;

EID: 0032212585     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80270-5     Document Type: Review

References (87)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 57:1974;775-788.
2. Gorevic PD, Kassab HJ, Levo Y, Konh R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long term follow up of 40 patients. Am J Med. 69:1980;287-308.
3. Meltzer M, Franklin EC. Cryoglobulinemia - a study of 29 patients. Am J Med. 40:1966;828-236.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 327:1992;1490-1495.
5. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 106:1994;1291-1300.
6. Manzin A, Solforosi L, Candela M, Cherubini G, Piccinini G, Brugia M, et al. Hepatitis C virus infection and mixed cryoglobulinaemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells. J Viral Hepat. 6:1996;285-292.
7. Kunkel H, Agnello V, Joslin F, Winchester R, Capra J. Cross idiotypic specificity among monoclonal IgM protein with anti-gammaglobulin activity. J Exp Med. 137:1973;331-341.
8. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med. 296:1997;1501-1504.
9. Popp JW, Dienstag JL, Wands JR, Bloch KJ. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med. 92:1984;379-383.
10. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis. 162:1990;569-570.
11. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 117:1992;573-577.
12. Cacoub P, Lunel-Fabiani F, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 96:1994;124-132.
13. Musset L, Dimert MC, Taibi F, Thi Huong Du L, Cacoub P, Leger JM, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem. 38:1992;798-802.
14. Pawlotsky JM, Ben Hayia M, André C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med. 122:1995;169-173.
15. Jori GP, Buonanno G, D'Onofrio F, Tirelli A, Gonnela F, Gentile S. Incidence and immunochemical features of serum cryoglobulin in chronic liver diseases. Gutt. 18:1977;245-249.
16. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C, et al. Secondary and essential cryoglobulinemia. Frequency, nosological classification and long term follow up. Acta Haematol. 70:1983;73-82.
17. Garcia-Bragado F, Biosca M, Villar M, De La Figuera M, Rodrigo MJ, Vilardell M. Maladies hépatiques et cryoglobulinémie mixte. Gastroenterol Clin Biol. 9:1984;456-457.
18. Zarski JP, Rougier D, Aubert H, Renversez JC, Cordonnier D, Stoebner P, et al. Association cryoglobuline et maladie hépatique: fréquence, nature et caractères immuno-chimiques de la cryoglobulinémie. Gastroenterol Clin Biol. 8:1984;845-850.
19. Bombardieri S, Ferri C, Di Munno O, Pasero G. Liver involvement in essential mixed cryoglobulinemia. Ric Clin Labo. 9:1979;361-368.
20. Roccatello D, Morsica G, Picciotto G, Ropolo R, Bernardi MT, Cacace G, et al. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection. Clin Exp Immunol. 110:1997;9-14.
21. Lunel F, Musset L. Hepatits C virus infection and cryoglobulinemia. Viral Hepatitis Review. 2:1996;111-124.
22. Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Acta Haematol. 79:1988;20-25.
23. Monteverde A, Sabattini E, Poggi S, Ballare M, Bertoncelli Mc, De Vivo A, et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma. 2:1995;1119-1124.
24. Monteverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol. 19:1997;99-110.
25. Koziel MJ, Walker BD. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection. Springer Semin Immunopathol. 19:1997;69-84.
26. Muratori L, Gibellini D, Lenzi M, Cataleta M, Muratori P, Morelli MC, et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood. 88:1996;2768-2774.
27. Zignego AL, Macchia D, Monti M, Thiers V, Mazetti M, Foshi M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 15:1992;382-386.
28. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis. 166:1992;1276-1280.
29. Hsieh TT, Yao DS, Sheen IS, Liaw YF, Pao C. Hepatitis C virus in peripheral blood mononuclear cells. Am J Clin Pathol. 98:1992;392-396.
30. Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danieli MG, et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. Clin Exp Immunol. 97:1994;87-93.
31. Koziel MJ. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepatitis. 4:1997;31-41. (Suppl 2).
32. Santini GF, Crovatto M, Modolo ML, Martelli P, Mazzi G, et al. Waldemström macroglobulinemia: a role of HCV infection. [Letter]? Blood. 82:1983;2932.
33. Mussini C, Ghini M, Mascia MT, Giovanardi P, Zanni G, Lattuada I, et al. Monoclonal gammapathies and hepatitis C virus infection. [Letter] Blood. 85:1995;1144-1145.
34. Ferri C, Caracciolo F, Zigneco AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 88:1994;392-394.
35. Sansonno D, Cornacchiulo V, Iacobelli AR, Gatti P, Distasi M, Dammaco F. Hepatitis C virus infection and clonal B-cell expansion. Clin Exp Rheumatol. 14:1996;S45-S50.
36. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica. 82:1997;314-317.
37. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 87:1996;4296-4301.
38. Zuckerman E, Zukerman T, Levine AM, Douer A, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 127:1997;423-428.
39. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 84:1994;3047-3053.
40. Ferri C, Caracciolo F, La Civita L, Monti M, Longombardo G, Greco F, et al. Hepatitis C virus infection and B-cell lymphomas. Eur J Cancer. 30:1994;1591-1592.
41. Zignego AL, Ferri C, Giannini C, La Civita L, Caressia G, Longombardo G, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol. 3:1997;545-555.
42. Pioltelli P, Zehender G, Monti G, Monteverde A, Galli M. HCV and non-Hodgkin lymphoma. Lancet. 347:1996;624-625.
43. Franzin F, Ebremov D, Pozzato G, Pussini E, Tulissi P, Burrone O. Monoclonal B-cell expansion, non-Hodgkin's lymphomas and HCV infection. [abstract]. J Hepatol. 23:1995;89. (Suppl 1).
44. Hanley J, Jarvis L, Simmonds P, Parker A, Ludlam C. HCV and non Hodgkin lymphoma. (letter) Lancet. 347:1996;1339.
45. McColl MD, Campbell Talt R. Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Haematol. 92:1996;771-772.
46. Nathwani BN, Mohrmann RL, Brynes RK, Taylor CR, Hansmann ML, Sheibani K. Monocytoid B-cell lymphoma: an assessment of diagnostic criteria and a perspective on histogenesis. Hum Pathol. 23:1992;1061-1071.
47. Ryan J, Wallace S, Jones P, Taggart G, Dudley F. Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Hepatol. 9:1994;308-310.
48. Andres E, Herbrecht R, Campos F, Marcellin L, Oberling F. Primary hepatic lymphoma associated with chronic hepatitis C. Ann Med Interne. 148:1997;280-283. (Paris).
49. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol. 90:1995;548-552.
50. Cordonnier DJ, Renversez JC, Vialtel P, Dechelette E. The kidney in mixed cryoglobulinemias. Springer Semin Immunopathol. 9:1987;395-415.
51. Marcellin P, Descamps V, Martinot-Peignoux M, Larque D, Xu L, Boyer N, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology. 104:1993;272-277.
52. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology. 25:1997;1237-1244.
53. Fornasieri A, Armelloni S, Bernasconi P, Li M, de Septis CP, Sinico RA, et al. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis. 27:1996;476-483.
54. Shibata T, Berney T, Spertini F, Izui S. Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice. Clin Exp Immunol. 87:1992;190-195.
55. Sansonno D, Cornacchiulov, Iacobelli AR, Di Stefano R, Lospalluti M, Dammaco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology. 21:1995;305-312.
56. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 40:1997;2007-2015.
57. Apartis E, Musset L, Gugenheim M, Cacoub P, Lyon-Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry. 60:1996;661-666.
58. Bonetti B, Invernizzi F, Rizzuto N, Bonazzi ML, Zanusso GL, Chinaglia G, et al. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol. 73:1997;145-154.
59. Coulie PG, Van Snick J. Rheumatoid factor (RF) production during anamnestic immune response in the mouse. III. Activation of RF precursor cells is induced by their interaction with immune complexes and carrier-specific helper T cells. J Exp Med. 161:1985;88-97.
60. Nemazee D. Immune complexes can trigger specific T cell-dependent autoanti-IgG antibody production in mice. J Exp MEd. 161:1985;242-256.
61. Goldfien RD, Fong S, Chen P, Carson DA. Structure and function of rheumatoid factor: implications for its role in the pathogenesis of mixed cryoglobulinemia. Pouticelli C. Antiglobulins, Cryoglobulins and Glomerulonephritis. 1986;17-27.
62. Miescher PA, Huang YP, Lzui S. Type II cryoglobulinemia. Semin Hepatol. 32:1995;80-85.
63. Agnello V. An immunological perspective on hepatitis C virus infection. Hepatology. 26:1997;1375-1379.
64. Major M, Feinstone S. The molecular biology of hepatitis C virus. Hepatology. 25:1997;1527-1538.
65. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasi-species and progression of liver disease. Hepatology. 20:1994;1144-1151.
66. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
67. Le Gruen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology. 25:1997;1250-1254.
68. Aiyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, et al. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatits C: relationship to antibody response against hypervariable region genome. Hepatology. 24:1996;1346-1350.
69. Willems M, Sheng L, Roskams T. Hepatitis C virus and its genotype in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol. 44:1994;266-271.
70. Frangeul L, Musset L, Cresta P, Cacoub P, Haraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol. 25:1996;427-432.
71. Van Thiel DH, Fagiuoli S, Caraceni P, Wright HI, Nadir A, Gavaler JS, et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol. 22:1995;464-467.
72. Lunel F. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology. 107:1994;1550-1555.
73. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology. 18:1993;816-822.
74. Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology. 20:1994;225-239.
75. Manns MP, Krüger M. Immunogenetics of chronic liver diseases. Gastroenterology. 106:1994;1676-1697.
76. Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 Antigen: a genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med. 154:1994;2733-2736.
77. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol. 10:1988;103-113.
78. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med. 83:1987;726-730.
79. Casato M, Lagana B, Antonelli G, Dianzani F, Bonomo L. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. Blood. 78:1991;3142-3147.
80. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis virus C infection. Blood. 90:1997;3865-3873.
81. Ferri C, Marzo M, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon alfa in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 81:1993;1132-1136.
82. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 330:1994;751-756.
83. Agnello V, Knight G, Abel G. Interferon alfa-2a for cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 331:1994;400.
84. Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Lacobelli AR, et al. Natural interferon alfa versus its combination with 6-methyl-prednisolone on the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood. 84:1994;3336-3343.
85. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perillo RP, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med. 321:1989;1501-1506.
86. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, et al. Recombinant human alpha-interferon in patients with chronic non-A non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology. 13:1991;393-397.
87. Chemello L, Cavalletto L, Noventa F, Bonetti P, Casarin C, Bernardinello E, et al. Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon alfa. J Viral Hepatitis. 2:1995;91-96.